The Cost of Medical Management in Advanced Heart Failure During the Final Two Years of Life

Journal of Cardiac Failure

Volumn 14, Issue 8, 2008, Pages 651-658

  Russo, Mark J ^a   Gelijns, Annetine C ^a   Stevenson, Lynne W ^d   Sampat, Bhaven ^a   Aaronson, Keith D ^c   Renlund, Dale G ^b   Ascheim, Deborah D ^a   Hong, Kimberly N ^a   Oz, Mehmet C ^a   Moskowitz, Alan J ^a   Rose, Eric A ^a   Miller, Leslie W ^e  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b LDS HOSPITAL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Cost; heart failure; human; medical therapy; treatment outcomes

Indexed keywords

AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; HEART FAILURE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT CARE; PRIORITY JOURNAL;

ACUTE DISEASE; AGE FACTORS; AGED; COST-BENEFIT ANALYSIS; DISEASE PROGRESSION; FEMALE; HEALTH RESOURCES; HEART FAILURE; HUMANS; MALE; MEDICARE; MODELS, ECONOMIC; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 52949111585     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.06.005     Document Type: Article

References (41)

1. American Heart Association. Heart disease and stroke statistics-2005 update (2005), American Heart Association, Dallas, TX
2. Stevenson L.W., Miller L.W., Desvigne-Nickens P., et al. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH. Circulation 110 (2004) 975-981
3. American Heart Association. New heart failure guidelines stress early diagnosis and treatment. Available at: http://www.americanheart.org/presenter.jhtml?identifier=3032954. Accessed October 5, 2006.
4. O'Connell J.B., and Bristow M. The economic impact of heart failure in the United States time for a different approach. J Heart Lung Transplant 13 (1994) S107-S112
5. Masoudi F.A., Baillie C.A., Wang Y., et al. Complexity and cost of multi-drug regimens of older patients hospitalized for heart failure. Arch Intern Med 165 (2005) 2069-2075
6. Mackowiak J. Cost of heart failure to the healthcare system. Am J Manag Care 4 (1998) S338-S342
7. Liu P., Arnold J.M., Belenkie I., et al. The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure. Can J Cardiol 31 19 (2003) 347-356
8. O'Connell J.B. The economic burden of heart failure. Clin Cardiol 23 (2000) III6-III10
9. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
10. Hunt S.A., Baker D.W., Chin M.H., et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure); International Society for Heart and Lung Transplantation; Heart Failure Society of America. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 104 (2001) 2996-3007
11. Cuzick J. A Wilcoxon-type test for trend. Stat Med 4 (1985) 87-90
12. In: Wennberg J.E., and Cooper M.M. (Eds). Dartmouth Atlas of Healthcare 1998 (1988), American Health Association Press, Chicago
13. Chang S., Long S.R., Kutikova L., Bowman L., Crown W.H., and Lyman G.H. Burden of pancreatic cancer and disease progression: economic analysis in the US. Oncology 70 (2006) 71-80
14. Hjelmgren J., Ceberg J., Persson U., and Alvegard T.A. The cost of treating pancreatic cancer-a cohort study based on patients' records from four hospitals in Sweden. Acta Oncol 42 (2003) 218-226
15. Au D.H., Udris E.M., Fihn S.D., McDonell M.B., and Curtis J.R. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med 166 (2006) 326-331
16. Shen A.Y.J., Wang X.Z., Doris J., and Moore N. Proportion of patients in a congestive heart failure care management program meeting criteria for cardiac resynchronization therapy. Am J Cardiol 94 (2004) 673-676
17. #. Gupta S.N., Jose V.J., and Chandy S.T. Heart failure: what proportion of patients satisfy the electrocardiographic criteria for cardiac resynchronization therapy?. Indian Heart J 55 (2003) 619-623 [Medline]
18. #. Guyomar Y., Houchaymi Z., Graux P., Heuls S., Rihani R., Cornaert P., Moulin C., Grimaud J.P., and Dutoit A. Indications for multisite pacing in patients with heart failure. Am J Cardiol 88 (2001) 688-690 [CrossRef][ISI][Medline]
19. #. Farwell D., Patel N.R., Hall A., Ralph S., and Sulke A.N. How many people with heart failure are appropriate for biventricular resynchronization?. Eur Heart J 21 (2000) 1246-1250 [Abstract/Free Full Text]
20. #. De Sutter J., De Bondt P., Van de Wiele C., Fonteyne W., Dierckx R., Clement D., and Taverni R. Prevalence of potential candidates for biventricular pacing among patients with known coronary artery disease: a prospective registry from a single center. Pacing Clin Electrophysiol 23 (2000) 1718-1721 [ISI][Medline]
21. #. Werling C., Weisse U., Siemon G., Kiessling A.H., Rameken M., Schwacke H., Saggau W., Senges J., and Seidl K. Biventricular pacing in patients with ICD: how many patients are possible candidates?. Thorac Cardiovasc Surg 50 (2002) 67-70 [CrossRef][ISI][Medline]
22. #. Grimm W., Sharkova J., Funck R., and Maisch B. How many patients with dilated cardiomyopathy may potentially benefit from cardiac resynchronization therapy?. Pacing Clin Electrophysiol 26 (2003) 155-157 [CrossRef][ISI][Medline]
23. #. Pedone C., Grigioni F., Boriani G., Lafiego C., Vassallo P.L., Potena L., Coccolo F., Magnani G., Biffi M., Martignani C., Frabetti L., Zannoli R., Magelli C., and Branzi A. Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation. Am J Cardiol 93 (2004) 371-373 [CrossRef][ISI][Medline]
24. Nohria A., Lewis E., and Stevenson L.W. Medical management of advanced heart failure. JAMA 6 287 (2002) 628-640
25. Willerson J.T., and Kereiakes D.J. Cardiac resynchronization therapy: helpful now in selected patients with CHF. Circulation 109 (2004) 308-309
26. Jauhar S., and Slotwiner D.J. The economics of ICDs. N Engl J Med 351 (2004) 2542-2544
27. Wachter R.M., Luce J.M., Hearst N., and Lo B. Decisions about resuscitation: inequities among patients with different diseases but similar prognoses. Ann Intern Med 111 (1989) 525-532
28. Levenson J.W., McCarthy E.P., Lynn J., Davis R.B., and Phillips R.S. The last six months of life for patients with congestive heart failure. J Am Geriatr Soc 48 (2000) S101-S109
29. Lynn J., Teno J.M., Phillips R.S., et al. Perceptions by family members of the dying experience of older and seriously ill patients. Ann Intern Med 126 (1997) 97-106
30. Goldstein N.E., and Lynn J. Trajectory of end-stage heart failure: the influence of technology and implications for policy change. Perspect Biol Med 49 (2006) 10-18
31. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
32. Emanuel E.J. Cost savings at the end of life: what do the data show?. JAMA 275 (1996) 1907-1914
33. Payne S.K. The health economics of palliative care. Oncology 16 (2002) 801-812
34. Lewina S.N., Buttina B.M., Powella M.A., et al. Resource utilization for ovarian cancer patients at the end of life: how much is too much?. Gynecol Oncol 99 (2005) 261-266
35. Morris J.N., Sherwood S., Wright S.M., and Gutkin C.E. The last weeks of life: does hospice care make a difference?. In: Mor V., Greer D.S., and Kastenbaum R. (Eds). The hospice experiment (1988), John Hopkins Press, Baltimore 109-132
36. Wallston K.A., Burger C., Smith R.A., and Baugher R.J. Comparing the quality of death for hospice and nonhospice cancer patients. Med Care 26 (1988) 177-182
37. Levy W.C., Mozaffarian D., Linker D.T., et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 21 113 (2006) 1424-1433
38. Lee D.S., Austin P.C., Rouleau J.L., Liu P.P., Naimark D., and Tu J.V. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 19 290 (2003) 2581-2587
39. Senni M., Santilli G., Parrella P., et al. A novel prognostic index to determine the impact of cardiac conditions and co-morbidities on one-year outcome in patients with heart failure. Am J Cardiol 15 98 (2006) 1076-1082
40. GC II F.J., and Butler J. End-of-life care for elderly patients with heart failure. Clin Geriatr Med 16 (2000) 663-675
41. Wachter R.M., Luce J.M., Hearst N., and Lo B. Decisions about resuscitation: inequities among patients with different diseases but similar prognoses. Ann Intern Med 111 (1989) 525-532